Impact of disparity of minor histocompatibility antigens HA-1, CD31, and CD49b in hematopoietic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors

Transplantation

Volumn 77, Issue 7, 2004, Pages 1103-1106

  Heinemann, Falko M ^a   Ferencik, Stanislav ^a   Ottinger, Hellmut D ^a   Beelen, Dietrich W ^a   Grosse Wilde, Hans ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; CD31 ANTIGEN; HA 1 ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; TRANSPLANTATION ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA POLYMORPHISM; DONOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SIBLING;

ADULT; ANTIGENS, CD31; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; INTEGRIN ALPHA2; LEUKEMIA, MYELOID, CHRONIC; MINOR HISTOCOMPATIBILITY ANTIGENS; OLIGOPEPTIDES; TISSUE DONORS;

EID: 1942535992     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000120175.25116.CB     Document Type: Article

References (10)

1. Tseng L-H, Lin M-T, Hansen JA, et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 1999; 94: 2911.
2. Gallardo D, Arostegui JI, Balas A, et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but is does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001; 114: 931.
3. Nichols WC, Antin JH, Lunetta KL, et al. Polymorphism of adhesion molecule CD31 is not a significant risk factor in graft versus host disease. Blood 1996; 88: 4429.
4. Maruya E, Saji H, Seki S, et al. Evidence that CD31, CD49b and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants. Blood 1998; 92: 2169.
5. Rozman P, Karas M, Kosir A, et al. Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation? Bone Marrow Transplant 2003; 31: 497.
6. Sidney J, Grey HM, Kubo RT, et al. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today 1996; 17: 261.
7. Smyth LA, Witt CS, Christiansen FT, et al. The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 351.
8. Weisdorf D, Hakke R, Blazar B, et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991; 51: 1197.]
9. Martin PJ, Gooley T, Anasetti C, et al. HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling. Biol Blood Marrow Transplant 1998; 4: 128.
10. Lin M-T, Gooley T, Hansen JA, et al. Absence of statistically significant correlation between disparity for the minor histocompatibility antigen HA-1 and outcome after allogeneic hematopoietic cell transplantation. Blood 2001; 98: 3172.